Cdc42-binding kinase

Cdc42-binding kinase, also known as myotonic dystrophy kinase-related Cdc42-binding kinase (MRCK), belongs to the DMPK family. Cdc42-binding kinase is an effector protein of Cdc42 and Rac1, a multi-domain protein of about 190kDa. Cdc42-binding kinase contains an N-terminal kinase domain, an intermediate coiled-coil domain, and a C-terminal regulatory domain (including C1, PH, CNH domains, and CRIB motifs). Cdc42-binding kinase exists as a homodimer, and the coiled-coil domain is about 55 nm long, which acts as a "molecular ruler" to locate the distance between the kinase domain and the membrane[1][2].
There are three subtypes of MRCK in humans: α, β, and γ. α and β are widely expressed, and γ is mainly expressed in muscle tissue. All three contain CRIB motifs and can bind to Cdc42/Rac1. The γ subunit has a preference for TC10[1][2].
Cdc42-binding kinase promotes actomyosin contraction by phosphorylating myosin regulatory light chain (MLC2) Ser19 and inhibiting myosin phosphatase (MLCP) subunit MYPT1, and participates in the establishment of cell polarity, directional migration, neurite growth, epithelial cell apical contraction, and cancer cell invasion. It can also phosphorylate LIMK1 to stabilize actin fibers.
Mechanistically, Cdc42-binding kinase binds to activated Cdc42-GTP through the CRIB motif, binds to membrane lipids such as phosphatidylserine (PS) with the help of C1 and PH domains, and localizes to the cell membrane; the coiled-coil domain mediates dimerization and maintains the active conformation of the kinase, binds to the actomyosin complex through the adaptor protein LRAP25/35a, such as LRAP35a mediating the binding of MRCK to MYO18A, and regulating the dynamics of lamellipodia actin fibers. At the same time, Cdc42-binding kinase participates in the Cdc42 and Rac1 signaling pathways, and is recruited to specific membrane regions by binding to GTP-formed Cdc42/Rac1, synergistically regulating the reorganization of the actin skeleton[1][2].
Interacting proteins of Cdc42-binding kinase include small GTPases CDC42 and Rac1, membrane lipids such as PS, inositol bisphosphates (PIPs), adaptor proteins LRAP25/35a, Shroom (ROCK-like adaptor protein), and actin-related proteins MYO18A and LIMK1[1][2].
Among the inhibitors of Cdc42-binding kinase, BDP5290 (HY-12437) is a selective inhibitor of MRCK, which is more than 50 times more selective for MRCKβ than ROCK and can block cancer cell invasion; Chelerythrine (HY-N2359) inhibits the activity of MRCK by binding to its C1 domain, affecting the formation of sheet-like actin fibers, with an IC50 of 1.8 μM, but there is a non-target effect[1][2].
In summary, MRCK abnormalities may be closely related to cancer cell migration and invasion, and its inhibitors are potential anticancer drugs. In developmental biology, MRCK is involved in embryonic gastrulation and the establishment of epithelial cell polarity, and its abnormal function may lead to developmental defects; in addition, the specific expression of MRCKγ in muscle tissue suggests that it may be associated with the pathological mechanism of muscle-related diseases such as myotonic dystrophy, but its specific role still needs further study[1][2].

Cdc42-binding kinase亚型特异性产品:Cdc42-binding kinase Isoform Comparison
共 1种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
4A-MPLA ammonium

4A-MPLA ammonium 是一种口服有效的 TLR4 激动剂,可诱导依赖于 Cdc42 和 galectin-3 的 TLR4 内吞作用,触发 TRIF 介导的信号通路并持续产生 IFN-β,促进脂滴形成,上调干扰素刺激基因和 I 型 IFN 信号通路基因,下调溶酶体/吞噬体功能基因,调节致耐受性树突状细胞的功能,并可用于结肠炎相关研究。

2260669-09-6
Activator
4A-MPLA ammonium

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础